Cited by 119Pancreatic function and diabetesCancer, Hypoxia, and MetabolismDiabetes and associated disorders

The hypoxia response pathway and β ‐cell function

Open access
Cantley, J., Grey, S. T., Maxwell, P. H., Withers, D. J.·2010·Diabetes, Obesity and Metabolism

Abstract

β ‐cells sense glucose and secrete appropriate amounts of insulin by coupling glucose uptake and glycolysis with quantitative ATP production via mitochondrial oxidative pathways. Therefore, oxidative phosphorylation is essential for normal β ‐cell function. Multiple cell types adapt to hypoxia by inducing a transcriptional programme coordinated by the transcription factor hypoxia‐inducible factor (HIF). HIF activity is regulated by the von Hippel–Lindau (Vhl) protein, which targets the HIF α subunit for proteasomal degradation in the presence of oxygen. Several recent studies have shown that Vhl deletion in β ‐cells results in Hif1 α activation, impaired glucose‐stimulated insulin secretion (GSIS) and glucose intolerance. This was found to be because of alterations in β ‐cell gene expression inducing a switch from aerobic glucose metabolism to anaerobic glycolysis, thus disrupting the GSIS triggering pathway. Situations in which islets may become hypoxic are discussed, in particular islet transplantation which has been reported to cause islet hypoxia because of an inadequate blood supply post‐transplant. Aside from this principal role for HIF in negatively regulating β ‐cell glucose sensing, other aspects of hypoxia signalling are discussed including β ‐cell differentiation, development and vascularization. In conclusion, recent studies clearly show that hypoxia response mechanisms can negatively impact on glucose sensing mechanisms in the β ‐cell and this has the potential to impair β ‐cell function in a number of physiological and clinical situations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2010.01276.x

Cites

0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hypoxic conditions and oxidative stress can also induce other stress pathways that result in β cell functional failure and apoptosis.

    “Hypoxic conditions and oxidative stress can also induce other stress pathways that result in β cell functional failure and apoptosis.”

    From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [133]

    The Hypoxic Response section says hypoxia activates stress pathways beyond HIF, and Hypoxia-independent Activation of HIF says oxidative stress may activate HIF in β-cells and cause secretory dysfunction. The paper mentions apoptosis in connection with pro-inflammatory cytokines, but does not say that hypoxia- or oxidative-stress-induced pathways cause β-cell apoptosis. The indexed passages provide no page numbers. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 56

  1. Mason SD, Rundqvist H, Papandreou I et al. HIF-1{alpha} in endurance training: suppression of oxidative metabolism. Am J Physiol Regul Integr Comp Physiol 2007; 293: R2059-R2069.
  2. Aragones J, Schneider M, Van Geyte K et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 2008; 40: 170-180.
  3. Zhong L, D'Urso A, Toiber D et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010; 140: 280-293.
  4. Park SK, Haase VH, Johnson RS. von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase. Int J Oncol 2007; 30: 341-348.
  5. Wang XL, Suzuki R, Lee K et al. Ablation of ARNT/HIF1beta in liver alters gluconeogenesis, lipogenic gene expression, and serum ketones. Cell Metab 2009; 9: 428-439.
  6. Halberg N, Khan T, Trujillo ME et al. HIF 1 alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 2009; 29: 4467-4483.
  7. Puri S, Cano D, Hebrok M. A role for Von-Hippel Lindau protein in pancreatic β-cell function. Diabetes 2008; 58: 433-441.
  8. Zehetner J, Danzer C, Collins S et al. PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells. Genes Dev 2008; 22: 3135-3146.
  9. Gunton JE, Kulkarni RN, Yim S et al. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005; 122: 337-349.
  10. Liu L, Cash TP, Jones RG, Keith B, Thompson CB, Simon MC. Hypoxia- induced energy stress regulates mRNA translation and cell growth. Mol Cell 2006; 21: 521-531.
  11. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447-5454.
  12. Lendahl U, Lee KL, Yang H, Poellinger L. Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet 2009; 10: 821-832.
  13. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514.
  14. Sogawa K, Nakano R, Kobayashi A et al. Possible function of Ah receptor nuclear translocator (Arnt) homodimer in transcriptional regulation. Proc Natl Acad Sci USA 1995; 92: 1936-1940.
  15. Antonsson C, Arulampalam V, Whitelaw ML, Pettersson S, Poellinger L. Constitutive function of the basic helix-loop-helix/PAS factor Arnt. Regulation of target promoters via the E box motif. J Biol Chem 1995; 270: 13968-13972.
  16. Jaakkola P, Mole DR, Tian YM et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472.
  17. Maxwell PH, Wiesener MS, Chang GW et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275.
  18. Ward JP. Oxygen sensors in context. Biochim Biophys Acta 2008; 1777: 1-14.
  19. Schuit FC, Huypens P, Heimberg H, Pipeleers DG. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 2001; 50: 1-11.
  20. Schuit F, De Vos A, Farfari S et al. Metabolic fate of glucose in purified islet cells. J Biol Chem 1997; 272: 18572-18579.
  21. Quintens R, Hendrickx N, Lemaire K, Schuit F. Why expression of some genes is disallowed in beta-cells. Biochem Soc Trans 2008; 36: 300-305.
  22. Gribble FM. Intolerant of glucose and gasping for oxygen. Nat Med 2009; 15: 247-249.
  23. Ainscow EK, Zhao C, Rutter GA. Acute overexpression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes 2000; 49: 1149-1155.
  24. Nicholls LI, Ainscow EK, Rutter GA. Glucose-stimulated insulin secretion does not require activation of pyruvate dehydrogenase: impact of adenovirus-mediated overexpression of PDH kinase and PDH phosphate phosphatase in pancreatic islets. Biochem Biophys Res Commun 2002; 291: 1081-1088.
  25. Heinis M, Simon M-T, Ilc K et al. Oxygen tension regulates pancreatic β- cell differentiation through hypoxia-inducible factor 1α. Diabetes 2010; 59: 662-669.
  26. Kaelin WG Jr. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res Commun 2005; 338: 627-638.
  27. Rankin EB, Rha J, Unger TL et al. Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 2008; 27: 5354-5358.
  28. Iturrioz X, Durgan J, Calleja V et al. The von Hippel-Lindau tumour- suppressor protein interaction with protein kinase C delta. Biochem J 2006; 397: 109-120.
  29. Okuda H, Saitoh K, Hirai S et al. The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J Biol Chem 2001; 276: 43611-43617.
  30. Dunwoodie SL. The role of hypoxia in development of the mammalian embryo. Dev Cell 2009; 17: 755-773.
  31. Kaelin WG, Iliopoulos O, Lonergan KM, Ohh M. Functions of the von Hippel-Lindau tumour suppressor protein. J Intern Med 1998; 243: 535-539.
  32. Woodward ER, Maher ER. Von Hippel-Lindau disease and endocrine tumour susceptibility. Endocr Relat Cancer 2006; 13: 415-425.
  33. Raval RR, Lau KW, Tran MG et al. Contrasting properties of hypoxia- inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 2005; 25: 5675-5686.
  34. Shen HCJ, Adem A, Ylaya K et al. Deciphering von Hippel-Lindau (VHL/Vhl)- associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations. PLoS One 2009; 4: e4897.
  35. Gnarra JR, Ward JM, Porter FD et al. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 1997; 94: 9102-9107.
  36. Haase VH, Glickman JN, Socolovsky M, Jaenisch R. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci USA 2001; 98: 1583-1588.
  37. Heiser PW, Lau J, Taketo MM, Herrera PL, Hebrok M. Stabilization of β- catenin impacts pancreas growth. Development 2006; 133: 2023-2032.
  38. Carlsson PO, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001; 50: 489-495.
  39. Lammert E, Gu G, McLaughlin M et al. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 2003; 13: 1070-1074.
  40. Miao G, Ostrowski RP, Mace J et al. Dynamic production of hypoxia- inducible factor-1alpha in early transplanted islets. Am J Transpl 2006; 6: 2636-2643.
  41. Juang JH, Hsu BR, Kuo CH, Uengt SW. Beneficial effects of hyperbaric oxygen therapy on islet transplantation. Cell Transpl 2002; 11: 95-101.
  42. Lehmann R, Zuellig RA, Kugelmeier P et al. Superiority of small islets in human islet transplantation. Diabetes 2007; 56: 594-603.
  43. Marselli L, Thorne J, Ahn YB et al. Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab 2008; 93: 1046-1053.
  44. Weir GC, Bonner-Weir S. A dominant role for glucose in beta cell compensation of insulin resistance. J Clin Invest 2007; 117: 81-83.
  45. Li X, Zhang L, Meshinchi S et al. Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes. Diabetes 2006; 55: 2965-2973.
  46. Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007; 293: E1118-E1128.
  47. Wang W, Upshaw L, Strong DM, Robertson RP, Reems J. Increased oxygen consumption rates in response to high glucose detected by a novel oxygen biosensor system in non-human primate and human islets. J Endocrinol 2005; 185: 445-455.
  48. Muraki I, Tanigawa T, Yamagishi K et al. Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Diabetologia 2010; 53: 481-488.
  49. Guzy RD, Hoyos B, Robin E et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metabolism 2005; 1: 401-408.
  50. Brunelle JK, Bell EL, Quesada NM et al. Oxygen sensing requires mito- chondrial ROS but not oxidative phosphorylation. Cell Metab 2005; 1: 409-414.
  51. Mansfield KD, Guzy RD, Pan Y et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-[alpha] activation. Cell Metab 2005; 1: 393-399.
  52. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-42354.
  53. Park Y-K, Ahn D-R, Oh M et al. Nitric oxide donor, ({+/-})-S-nitroso- N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor- 1{alpha} by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation. Mol Pharmacol 2008; 74: 236-245.
  54. Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor- interacting protein-dependent nuclear factor kappa B activation. Biochem J 2003; 370: 1011-1017.
  55. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated up- regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003; 17: 2115-2117.
  56. Sandler S, Andersson A, Hellerstrom C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424-1431.

Cited by

Sorted by citations

Authors
Cantley, J., Grey, S. T., Maxwell, P. H., & Withers, D. J.
Affiliations
  • Garvan Institute of Medical Research (AU)
  • University College London (GB)
Corresponding author
Cantley, J.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2010-10
Volume
12
Issue
s2
Pages
159-167
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2084708745
Cited by
119
References
0
Citations by year
2026: 4 · 2025: 8 · 2024: 8 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 10 · 2019: 6 · 2018: 6 · 2017: 11 · 2016: 9 · 2015: 6 · 2014: 10 · 2013: 9 · 2012: 9
FWCI
1.14
Type
journal article
Language
en
Open access
Locations
  • Diabetes Obesity and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
hypoxia response, pancreatic beta cells, hypoxia-inducible factor, von Hippel-Lindau protein, HIF-1α, glucose-stimulated insulin secretion, glucose detection, oxidative phosphorylation, anaerobic glycolysis, islet transplantation, beta cell differentiation, islet vascularization, impaired glucose tolerance
MeSH terms
Insulin Secretion, Animals, Blood Glucose, Glycolysis, von Hippel-Lindau Disease, Humans, Insulin, Oxygen, Phosphorylation, Cell Hypoxia, Insulin-Secreting Cells, Mice, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review